查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493484

人造心臟市场规模、份额、趋势分析报告：按类型、治疗方法、地区、细分市场预测，2024-2030

Artificial Heart Market Size, Share & Trends Analysis Report By Type (Heart-lung Machine, Total Artificial Heart), By Therapy (Destination Therapy, Bridge To Transplant, Bridge To Decision), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

人工心臟市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球人造心臟市场规模将达到59.4亿美元，2024年至2030年复合年增长率为11.3%。

由于多种因素的影响，该市场正在经历显着增长，包括心血管疾病负担的增加、该领域的技术进步、老年人口的增加以及导致心血管风险增加的生活方式的改变。随着世界人口老化，老年人心臟病的发生率不断增加。这种人口趋势增加了对人造心臟的需求，作为心臟衰竭等疾病的治疗选择。

由于人口老化、久坐的生活方式和不健康的饮食，全球心血管疾病的负担正在增加。根据 NCBI 2022 年 5 月的一篇报导，9,210 万美国人患有某种形式的 CVD，预计到 2030 年，43.9% 的人患有某种形式的 CVD。同样，根据英国心臟基金会 2022 年 7 月的报告，2021 年将有 400 万名男性和 360 万名女性患有心臟和循环系统疾病。对旨在改善心臟病患者预后的研究的持续投资正在推动人造心臟的采用率。 2024 年 1 月，CARMAT 宣布对 Aeson 人工心臟进行新的软体增强，旨在透过实现即时缺陷检测和控制变更来增强其安全性，以提供持续的患者照护。

人造心臟市场报告亮点

  • 从类型来看，左心室辅助装置（LVAD）领域将占据最大的市场占有率，2023年将达到77.40%。全球心臟衰竭盛行率的上升对 LVAD 市场的成长做出了重大贡献。
  • 根据治疗方法，目的地治疗细分市场预计将在 2023 年占据最高收益占有率，达到 61.8%，并在预测期内呈现最快的复合年增长率，达到 11.8%。
  • 2023年，北美以64.1%的市占率主导市场。这得归功于该地区先进的医疗基础设施、优惠的报销政策和技术进步。 Abbott、BiVacor 和 SynCardia 等主要市场参与者主导了该地区的市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章人造心臟市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 人工心臟市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 人工心臟市场：类型估算与趋势分析

  • 人造心臟市场：类型仪表板
  • 人工心臟市场：类型波动分析
  • 2018-2030年人工心臟市场规模及预测与趋势分析（按类型）
  • LVAD
  • 心肺机
  • 全人工心臟

第五章 人工心臟市场：治疗方法估算与趋势分析

  • 人造心臟市场：治疗方法板
  • 人工心臟市场：治疗方法变异分析
  • 2018-2030年人工心臟市场规模、预测与趋势分析（依治疗方法）
  • BTT
  • DT
  • BTD
  • 其他的

第六章 人工心臟市场：按国家、类型和治疗方法进行的区域估计和趋势分析

  • 人造心臟市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • SynCardia Systems, LLC
    • CARMAT
    • BiVacor
    • RealHeart
    • Abbott
    • Abiomed（Johnson &Johnson Services Inc）
    • Jarvik Heart, Inc
    • LivaNova PLC
    • Getinge AB
    • Terumo
Product Code: GVR-4-68040-275-4

Artificial Heart Market Growth & Trends:

The global artificial heart market size is expected to reach USD 5.94 billion by 2030, registering a CAGR of 11.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by various factors such as the increasing burden of cardiovascular diseases, technological advancements in the field, a growing geriatric population, and lifestyle changes leading to higher cardiovascular risks. As the global population ages, there is an increased incidence of cardiac issues among older individuals. This demographic trend contributes to the demand for artificial hearts as a treatment option for heart failure and other conditions.

The global burden of CVDs is increasing, driven by the aging population, sedentary lifestyles, and unhealthy diets. According to an article by NCBI in May 2022, 92.1 million Americans are affected by some form of CVD, and it is predicted that 43.9% will have some type of CVD by 2030. Similarly, according to the British Heart Foundation's July 2022 report, 4 million men and 3.6 million women lived with heart and circulatory diseases in 2021. Continued investment in research aimed at improving cardiac patient outcomes drives adoption rates for artificial hearts. In January 2024, CARMAT introduced a new software enhancement for its artificial heart Aeson, aiming to enhance its safety profile by enabling real-time defect detection and modifying control to provide continuous patient care.

Artificial Heart Market Report Highlights:

  • Based on type, the left ventricular assist device (LVAD) segment held the largest market share of 77.40% in 2023. The rising prevalence of heart failure globally has contributed significantly to the growth of the LVAD market
  • Based on therapy, the destination therapy segment accounted for the largest revenue share of 61.8% in 2023 and is expected to witness the fastest CAGR of 11.8% during the forecast period. owing to the increasing prevalence of advanced heart failure patients who are ineligible for heart transplantation or other therapies
  • In 2023, North America dominated the market with a share of 64.1% due to the advanced healthcare infrastructure, favorable reimbursement policies, and technological advancements in the region. The presence of major market players such as Abbott, BiVacor and SynCardia dominates the market in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Therapy
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. Commodity price analysis (Model 1)
  • 1.9. Approach 1: Commodity flow approach
  • 1.10. List of Secondary Sources
  • 1.11. List of Primary Sources
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Therapy outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Heart Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver Analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Artificial Heart Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Artificial Heart Market: Type Estimates & Trend Analysis

  • 4.1. Artificial Heart Market: Type Dashboard
  • 4.2. Artificial Heart Market: Type Movement Analysis
  • 4.3. Artificial Heart Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. LVADs
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Heart-lung Machine
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Total Artificial Heart
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Artificial Heart Market: Therapy Estimates & Trend Analysis

  • 5.1. Artificial Heart Market: Therapy Dashboard
  • 5.2. Artificial Heart Market: Therapy Movement Analysis
  • 5.3. Artificial Heart Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 5.4. Bridge to transplant
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Destination Therapy
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Bridge to decision
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Artificial Heart Market: Regional Estimates & Trend Analysis by Country, Type & Therapy

  • 6.1. Artificial Heart Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. SynCardia Systems, LLC
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. CARMAT
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. BiVacor
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. RealHeart
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Abbott
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Abiomed (Johnson & Johnson Services Inc)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Jarvik Heart, Inc
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. LivaNova PLC
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Getinge AB
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Terumo
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 6 U.S. artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 8 Canada artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 9 Canada artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 10 Europe artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 12 Europe artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 13 UK artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 14 UK artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 15 Germany artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 16 Germany artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 17 France artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 18 France artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 19 Italy artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 20 Italy artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 21 Spain artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 22 Spain artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 23 Denmark artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 24 Denmark artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 25 Sweden artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 26 Sweden artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 27 Norway artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 28 Norway artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 32 Japan artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 33 Japan artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 34 China artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 35 China artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 36 India artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 37 India artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 38 Australia artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 39 Australia artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 40 South Korea artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 41 South Korea artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 42 Thailand artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 43 Thailand artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 44 Latin America artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 45 Latin America artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 46 Latin America artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 47 Brazil artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 48 Brazil artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 49 Mexico artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 50 Mexico artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 51 Argentina artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 52 Argentina artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 53 MEA artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 54 MEA artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 55 MEA artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 56 South Africa artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 60 UAE artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 62 Kuwait artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait artificial heart market, by therapy , 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Artificial heart market segmentation
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Artificial heart type market share analysis, 2023 & 2030
  • Fig. 14 Artificial heart type market: Segment dashboard
  • Fig. 15 LVADs market estimates and forecast, 2018 - 2030
  • Fig. 16 Heart-lung machine market estimates and forecast, 2018 - 2030
  • Fig. 17 Total artificial heart market estimates and forecast, 2018 - 2030
  • Fig. 18 Artificial heart therapy market share analysis, 2023 & 2030
  • Fig. 19 Artificial heart therapy market: Segment dashboard
  • Fig. 20 Bridge to transplant market estimates and forecasts, 2018 - 2030
  • Fig. 21 Destination therapy market estimates and forecasts,2018 - 2030
  • Fig. 22 Bridge to decision market estimates and forecasts, 2018 - 2030
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030
  • Fig. 24 Artificial heart regional market share analysis, 2023 & 2030
  • Fig. 25 Artificial heart regional market: Segment dashboard
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Company market position analysis